Your browser doesn't support javascript.
loading
Delivery Device Patents on GLP-1 Receptor Agonists.
Alhiary, Rasha; Gabriele, Sarah; Kesselheim, Aaron S; Tu, S Sean; Feldman, William B.
Afiliación
  • Alhiary R; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gabriele S; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
  • Tu SS; West Virginia University College of Law, Morgantown.
  • Feldman WB; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA ; 331(9): 794-796, 2024 03 05.
Article en En | MEDLINE | ID: mdl-38315473
This study analyzed the US Food and Drug Administration­listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Patentes como Asunto / Diabetes Mellitus Tipo 2 / Legislación de Dispositivos Médicos / Agonistas Receptor de Péptidos Similares al Glucagón / Hipoglucemiantes Límite: Humans Idioma: En Revista: JAMA Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Patentes como Asunto / Diabetes Mellitus Tipo 2 / Legislación de Dispositivos Médicos / Agonistas Receptor de Péptidos Similares al Glucagón / Hipoglucemiantes Límite: Humans Idioma: En Revista: JAMA Año: 2024 Tipo del documento: Article